Express Scripts Holding Current Ratio 2006-2018 | ESRX

Current and historical current ratio for Express Scripts Holding (ESRX) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Express Scripts Holding current ratio for the three months ending September 30, 2018 was 0.77.
Express Scripts Holding Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $14.35B $18.69B 0.77
2018-06-30 $13.17B $18.59B 0.71
2018-03-31 $11.48B $16.72B 0.69
2017-12-31 $11.96B $17.85B 0.67
2017-09-30 $12.68B $17.36B 0.73
2017-06-30 $11.64B $16.78B 0.69
2017-03-31 $12.09B $17.04B 0.71
2016-12-31 $12.36B $16.43B 0.75
2016-09-30 $11.12B $15.98B 0.70
2016-06-30 $10.62B $19.14B 0.56
2016-03-31 $10.40B $17.24B 0.60
2015-12-31 $12.06B $17.16B 0.70
2015-09-30 $10.27B $16.01B 0.64
2015-06-30 $9.64B $15.87B 0.61
2015-03-31 $9.17B $14.90B 0.62
2014-12-31 $10.57B $17.01B 0.62
2014-09-30 $9.71B $15.92B 0.61
2014-06-30 $10.45B $15.98B 0.65
2014-03-31 $8.13B $13.58B 0.60
2013-12-31 $8.49B $13.24B 0.64
2013-09-30 $9.22B $11.23B 0.82
2013-06-30 $8.30B $10.62B 0.78
2013-03-31 $8.71B $11.52B 0.76
2012-12-31 $10.76B $13.06B 0.82
2012-09-30 $9.43B $11.79B 0.80
2012-06-30 $9.66B $12.84B 0.75
2012-03-31 $12.10B $5.67B 2.14
2011-12-31 $8.06B $5.46B 1.48
2011-09-30 $3.31B $5.14B 0.64
2011-06-30 $2.70B $4.76B 0.57
2011-03-31 $3.15B $3.71B 0.85
2010-12-31 $2.94B $3.92B 0.75
2010-09-30 $2.55B $3.97B 0.64
2010-06-30 $3.81B $4.87B 0.78
2010-03-31 $4.04B $5.19B 0.78
2009-12-31 $4.14B $5.46B 0.76
2009-09-30 $6.74B $3.06B 2.21
2009-06-30 $6.34B $2.87B 2.21
2009-03-31 $2.26B $2.87B 0.79
2008-12-31 $2.04B $2.72B 0.75
2008-09-30 $1.80B $2.55B 0.70
2008-06-30 $1.81B $2.52B 0.72
2008-03-31 $2.08B $2.57B 0.81
2007-12-31 $1.97B $2.48B 0.80
2007-09-30 $1.70B $2.39B 0.71
2007-06-30 $1.75B $2.34B 0.75
2007-03-31 $1.88B $2.44B 0.77
2006-12-31 $1.77B $2.43B 0.73
2006-09-30 $1.73B $2.32B 0.74
2006-06-30 $1.84B $2.18B 0.85
2006-03-31 $2.21B $2.22B 1.00
2005-12-31 $2.26B $2.40B 0.94
2005-09-30 $1.62B $1.88B 0.86
2005-06-30 $1.71B $1.89B 0.91
2005-03-31 $1.57B $1.86B 0.85
Sector Industry Market Cap Revenue
Medical Medical Services $55.371B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.464B 23.39
PRA Health Sciences (PRAH) United States $6.655B 27.17
Charles River Laboratories (CRL) United States $6.430B 22.55
HealthEquity (HQY) United States $5.667B 118.62
Premier (PINC) United States $5.378B 18.33
INC Research Holdings (SYNH) United States $5.176B 20.89
Teladoc (TDOC) United States $4.246B 0.00
NovoCure (NVCR) Jersey $2.842B 0.00
AMN Healthcare Services Inc (AMN) United States $2.708B 18.58
Medpace Holdings (MEDP) United States $2.063B 25.52
BioTelemetry (BEAT) United States $2.054B 36.28
Healthways (TVTY) United States $1.488B 18.31
Intrexon (XON) United States $1.372B 0.00
IKang Healthcare (KANG) China $1.081B 53.69
CareDx (CDNA) United States $1.071B 0.00
Natera (NTRA) United States $0.969B 0.00
China Cord Blood (CO) China $0.801B 21.26
Surgery Partners (SGRY) United States $0.685B 0.00
Apollo Medical Holdings (AMEH) United States $0.612B 0.00
Civitas Solutions (CIVI) United States $0.525B 10.34
Establishment Labs Holdings (ESTA) $0.512B 0.00
OncoCyte (OCX) United States $0.074B 0.00
Interpace Diagnostics (IDXG) United States $0.042B 0.00
Cancer Genetics (CGIX) United States $0.016B 0.00
OpGen (OPGN) United States $0.008B 0.00
FORM Holdings (XSPA) United States $0.004B 0.00
Biocept (BIOC) United States $0.004B 0.00